# Nuclide record f-18-fluorothymidine (drug). Data CC BY-NC 4.0, attribute "Data from Nuclide (nuclide.cc)". Whole corpus: https://nuclide.cc/api/v1/nuclide.nt
@prefix schema: <https://schema.org/> .
@prefix nuclide: <https://nuclide.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://nuclide.cc/drugs/f-18-fluorothymidine/>
  a schema:Drug ;
  nuclide:kind "drug" ;
  schema:identifier "f-18-fluorothymidine" ;
  schema:name "Fluorothymidine F-18 (FLT)"@en ;
  schema:alternateName "18F-FLT"@en, "3'-deoxy-3'-[18F]fluorothymidine"@en ;
  schema:description "An experimental PET tracer that measures how fast tumour cells are dividing, rather than how much sugar they burn. It has been studied in research settings for over 20 years but has never been approved as a medicine."@en ;
  schema:url <https://nuclide.cc/drugs/f-18-fluorothymidine/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://dctd.cancer.gov/drug-discovery-development/reagents-materials/imaging-ind-resources/documentation/flt-ib.pdf>, <https://pmc.ncbi.nlm.nih.gov/articles/PMC4415691/>, <https://snmmi.org/common/Uploaded%20files/Web/Centers/PET%20Center%20of%20Excellence/FLT_07-11-12%20Final.pdf> ;
  nuclide:status "phase-2" ;
  nuclide:tag "proliferation imaging", "investigational", "TK1" ;
  nuclide:modality "PET tracer" ;
  nuclide:related <https://nuclide.cc/isotopes/f-18/> ;
  nuclide:indications <https://nuclide.cc/indications/breast-her2-positive/>, <https://nuclide.cc/indications/glioblastoma/>, <https://nuclide.cc/indications/nsclc/> ;
  nuclide:technologies <https://nuclide.cc/technologies/pet/> .